Your session is about to expire
← Back to Search
Fascia Iliaca Compartment Block for Hip Arthritis
Phase 4
Waitlist Available
Led By Michael Charters, MD
Research Sponsored by Henry Ford Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post operative day one
Awards & highlights
Study Summary
The fascia iliaca compartment block (FICB) is a regional block that anesthetizes the femoral, obturator, and lateral femoral cutaneous nerves around the hip. The purpose of this study is to determine whether FICB can reduce postoperative pain and increase progress with physical therapy after total hip arthroplasty (THA). This randomized, double-blind, clinical trial will randomize patients to receive either a FICB or placebo after THA. The primary outcomes will be pain scores reported by the patient post-operatively.
Eligible Conditions
- Hip Arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ postoperative inpatient stay, which averages approximately two days.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~postoperative inpatient stay, which averages approximately two days.
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Averaged Pain Score
Morphine Equivalents Consumed
Secondary outcome measures
Time to Discharge Readiness
Time to Up-and-go
Walking Distance
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Fascia Iliaca Compartment BlockExperimental Treatment2 Interventions
A Fascia Iliaca Compartment Block will be administered in the block room.
Group II: ControlPlacebo Group1 Intervention
The patients will be brought back to the block room, prepped, and a blunt needle will be touched to the skin. A band aid will be applied over the site.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Fascia iliaca compartment block
2010
Completed Phase 4
~760
Find a Location
Who is running the clinical trial?
Henry Ford Health SystemLead Sponsor
300 Previous Clinical Trials
2,099,760 Total Patients Enrolled
Michael Charters, MDPrincipal InvestigatorHenry Ford Hospital
2 Previous Clinical Trials
210 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger